🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical research study is to learn if the combination of ...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2003-09
Trial ID
NCT00504660
Treatments Being Tested
This is a phase I study of second primary tumor prevention in early stage (...
Status
Completed
Location
Emory University Winship Cancer Institute
Start Date
2007-08
Trial ID
NCT00400374
It has been found that the chemical changes that take place in a patient's ...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT02429427
Phase I study designed to test the hypothesis that overencapsulated celecox...
Status
Completed
Location
Research
Start Date
2008-07
Trial ID
NCT00729495
Treatments Being Tested
Cyclooxygenase-2 (COX-2) is frequently over-expressed in primary breast can...
Status
Completed
Location
University Hospital Maastricht
Start Date
2004-02
Trial ID
NCT01695226
Primary Objective: * To determine whether celecoxib downregulates GATA-6 e...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2003-08-20
Trial ID
NCT00503035
Treatments Being Tested
The objective of this exploratory study is to evaluate the cellular and con...
Status
Terminated
Location
Regeneron Research Site
Start Date
2019-04-08
Trial ID
NCT03949673
Treatments Being Tested
This randomized, single blinded, clinical trial aims to investigate the eff...
Status
Active Not Recruiting
Location
Henry Ford Health
Start Date
2022-06-25
Trial ID
NCT05488847
This early phase IIA trial studies how well celecoxib, recombinant interfer...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2018-04-19
Trial ID
NCT03403634
Treatments Being Tested
The purpose of this study is to find out if giving a medicine called furose...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2015-02
Trial ID
NCT02351934
Treatments Being Tested